A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Extravasation
Interventions
DRUG

Dexrazoxane

Trial Locations (34)

2100

Rigshospitalet, Haematology Department, Copenhagen

Rigshospitalet, Oncology Department, Copenhagen

2730

Herlev County Hospital, Haematology Department, Herlev

Herlev County Hospital, Oncology Department, Herlev

3400

Hilleroed Hospital, Hilleroed

4000

Roskilde County Hospital, Roskilde

4700

Naestved District Hospital, Næstved

6400

Soenderborg Hospital, Sønderborg

6700

Esbjerg District Hospital, Esbjerg

7100

Vejle Hospital, Vejle

8800

Viborg Hospital, Viborg

9100

Aalborg Hospital South, Aalborg

18057

Universitäts Frauenklinik, Rostock

20246

Klinik und Poliklinik für Innere Medizin, Hamburg

24105

Universitäts Frauenklinik, Kiel

Universitäts Medizinische Klinik, Kiel

30659

Medizinische Hochschule Hannover, Hanover

34100

Ospedali Riuniti, Trieste

45355

Evangelisches Bethesda Krankenhaus, Essen Borbak Statt

47037

Ospedale degli Infermi, Rimini

47100

Ospedale G.B. Morgagni L. Pierantoni, Forlì

48100

Presidio Ospedaliero di Ravenna, Ravenna

60590

Klinik für Gynäkologie und Geburtshilfe, Frankfurt am Main

65199

Klinik für Gynäkologie und Gynäkologische Onkologie, Wiesbaden

80637

Frauenklinik com Roten Kreuz, Munich

8000 C

Aarhus County Hospital, Aarhus

Aarhus Municipality Hospital, Aarhus

5000 C

Odense University Hospital, Odense

5223 GV

Willem Alexander Hospital, 's-Hertogenbosch

1066 CX

Netherland Cancer Institute, Amsterdam

9700 RB

University Hospital, Groningen

31-115

Centre of Oncology - Krakow Division, Krakow

02-781

Maria Sklodowska-Curie Memorial Cancer Center, Warsaw

53-413

Dolnoslaski Centrum Onkologii oddzial Chemoterapii, Wroclaw

Sponsors
All Listed Sponsors
lead

Valerio Therapeutics

INDUSTRY

NCT00548704 - A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines | Biotech Hunter | Biotech Hunter